Top 35 Companies in In-Vivo Imaging Market 2025: Strategic Overview and Future Trends (2024–2035)

Description

According to a research report published by Spherical Insights & Consulting, The Global In-Vivo Imaging Market Size is projected To Grow from USD 3.20 Billion in 2024 to USD 5.54 Billion by 2035, at a CAGR of 5.12% during the forecast period of 2025–2035.  The primary drivers of the market are the increased R&D funding and improvements in hybrid imaging systems. For example, Revvity Inc., a major imaging vendor, recently launched new imaging systems and formed partnerships with companies for improved capabilities in preclinical research. Other market drivers include the increase in chronic diseases and the need for advanced imaging technologies for drug discovery and clinical applications.

Introduction

The Global industry of in-vivo imaging includes methods and systems for non-invasively observing and investigating biological processes within living creatures, with a focus on medication discovery, illness research, and clinical diagnostics. Seeing anatomical features, molecular activity, and metabolic processes as they naturally occur within entire organisms is made easier with the use of in vivo imaging. The necessity for in vivo imaging to be used in conjunction with nuclear and optical imaging is ultimately driven by the growing preference for precision medicine and the important role that molecular imaging plays as companion diagnostics. Technological advancements in image fusion, contrast agents, and functional imaging have opened up wide-ranging possibilities in oncology, neurology, and cardiovascular research. Growth in preclinical and translation research with favorable regulatory conditions is contributing to the widespread uptake of imaging systems for use in both clinical and academic practice. The increased need for accurate biomarker tracking and therapy effectiveness will continue to create opportunities for market growth as healthcare systems and technologies continue to evolve into more evidence based approaches to planning, assessing, and monitoring treatment.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights - Download the Brochure now and dive deeper into the future of the In-Vivo Imaging Market.

 

In-Vivo Imaging Market Size & Statistics

• The Market Size for In-Vivo Imaging Was Estimated to be worth USD 3.20 Billion in 2024.
• The Market Size is going to expand at a CAGR of 5.12% between 2025 and 2035.
• The Global In-Vivo Imaging Market Szie is anticipated to reach USD 5.54 billion by 2035.
• North America is expected to generate the highest demand during the forecast period in the In-Vivo Imaging Market.
• Asia Pacific is expected to grow the fastest during the forecast period in the In-Vivo Imaging Market.

Regional growth and demand

 

North America is expected to generate the highest demand during the forecast period in the In-Vivo Imaging Market. With growing R&D activities and a preference for projects that employ non-invasive, high-resolution, and data-intensive approaches, the market ecosystem in North America is robust. The growth of contract research organizations, government-funded projects, and collaborative research has all contributed to the demand for in-vivo imaging. Due in large part to the existence of biotech and pharmaceutical companies, federal research funding, and effective supply chain management, the US is currently leading the region's in-vivo imaging market.

 

Asia Pacific is expected to grow the fastest during the forecast period in the In-Vivo Imaging Market.

The in-vivo imaging market in the Asia Pacific region is flourishing due to rising investments and funding from major businesses and governments in nations like China and India. Countries like China, Japan, and South Korea have grown to be significant players in the healthcare industry because their governments actively encourage the development of healthcare infrastructure. Multinational corporations are spending more on the development of in-vivo imaging in emerging nations like China and India due to the growing need for reasonably priced treatment solutions.

 

Top 10 Trends in the In-Vivo Imaging Market

• Incorporating Artificial Intelligence (AI) & Machine Learning (ML) into imaging
• Multi-modal imaging system adoption
• Increase in Small Animal Models and Preclinical Imaging 
• Development of imaging modalities that are non-invasive or minimally invasive
• Increased utilization and availability caused by chronic conditions & personalized medicine
• Creation of innovative imaging probes and contrast agents
• Compact and portable imaging devices
• Chronic illnesses and aging populations are driving demand.
• Integration of theranostics and precision medicine
• Increased ethical and regulatory demands

 

1. Incorporating Artificial Intelligence (AI) & Machine Learning (ML) into imaging

AI/ML applications have been utilized to analyze imaging data more quickly and accurately, identifying patterns or anomalies that may be more subtle for a human observer. Implementation of AI/ML for imaging allows for faster diagnoses, improved reproducibility, fewer errors, and improved performance in the decision-making of healthcare professionals. AI/ML tools are very useful when dealing with larger datasets, longitudinal studies, or multi-center studies.

 

2. Multi-modal imaging system adoption

Combining two or more imaging modalities gives complementary information, anatomical plus functional, molecular, or cellular. Better illness identification, staging, and therapy monitoring are made possible by this. These technologies are becoming more and more popular among academics and doctors for precision diagnosis, especially in oncology.

 

3. Increase in Small Animal Models and Preclinical Imaging 

Preclinical studies refer to experimentation in small animal models (e.g., rodents) for drug testing, studying mechanisms of disease, and following biological systems in vivo. In preclinical research, more and more imaging systems are demanded to meet the needs of small-animal studies, particularly non-invasive and higher resolution systems, which can provide stronger and more translatable results as compared to traditional imaging methods. This trend contributes to increased value and reduced costs in R&D, expedited R&D timelines, and improved responsible research practices.

 

4. Development of imaging modalities that are non-invasive or minimally invasive

Patients, researchers, and clinicians are increasingly choosing imaging modalities that do not involve surgery or substantial intervention, reducing risk, discomfort, and recovery time. Technologies such as optical imaging, fluorescence, and photoacoustic imaging are being developed for improved depth of field, resolution, and safety, and they are allowing for the early detection of chronic diseases through more frequent monitoring and assessment.

 

5. Increased utilization and availability caused by chronic conditions & personalized medicine

 With the rise of chronic diseases such as cancer, cardiovascular disease, and neurological disorders, the demand for imaging tools to detect, monitor, and treat patients continues to rise. Furthermore, personalized medicine, which is increasingly being used, relies on understanding each patient's biology, including molecular-level and functional imaging, to apply selected therapies. In-vivo imaging methods are integral to this, as they provide non-invasive insight into the mechanisms of disease in individual patients.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the In-Vivo Imaging market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Top 25 Companies Leading the In-Vivo Imaging Market

• PerkinElmer Inc.
• Bruker Corporation
• Siemens Healthineers AG
• FUJIFILM VisualSonics Inc.
• MILabs B.V. (Rigaku Company)
• Thermo Fisher Scientific Inc.
• Mediso Medical Imaging Systems Ltd.
• LI-COR Biosciences
• MR Solutions Ltd.
• Aspect Imaging Ltd.
• TriFoil Imaging
• Agilent Technologies Inc.
• Carestream Health
• Spectrum Dynamics Medical
• Promega Corporation
• Bio-Rad Laboratories Inc.
• Bracco Imaging S.p.A.
• Trieste S.p.A.
• Miltenyi Biotec GmbH
• Sofie Biosciences Inc.
• GE HealthCare Technologies Inc.
• SCANCO Medical AG
• Photon etc. Inc.
• Ellex Medical Lasers Ltd.
• Advanced BioPhotonics Inc.
• Others

 

1. PerkinElmer Inc.

Headquarters: Waltham, Massachusetts, USA

PerkinElmer Inc. is a global leader in life sciences, diagnostics, and imaging technologies. In the In-Vivo Imaging Market, it is known for its leading-edge preclinical imaging systems (optical, PET, and CT), which specialize in improving drug discovery and molecular imaging research. PerkinElmer is also at the forefront of innovation, data integration, and AI-based analysis to take advantage of imaging sensitivity and throughput. With a firm position in research institutions and biopharma, the company is defining the future of non-invasive imaging as a diagnostic and treatment monitoring tool as part of health care, and re-establishing its position as a leader in life science instrumentation and in-vivo imaging innovation.

 

2. Bruker Corporation

Headquarters: Billerica, Massachusetts, USA

Bruker Corporation is a well-known company specializing in scientific instruments and analytical solutions. Bruker provides incredibly innovative preclinical imaging systems that fuse molecular, functional, and anatomical data in the In-Vivo Imaging Market. The company continues to innovate for its clients, providing high-resolution imaging and advanced analysis software, thereby advancing drug development and translational research. Bruker’s BioSpec and SkyScan product lines are popular and utilized by academic and pharmaceutical researchers.

 

3. Siemens Healthineers AG

Headquarters: Erlangen, Germany

Siemens Healthineers AG is a large international medical technology corporation that is recognized for its cutting-edge imaging technologies and digital health platform. Siemens Healthineers achieves this by offering cutting-edge PET/CT, MRI, and hybrid imaging tools related to the In-Vivo Imaging Market that facilitate early disease detection and precision diagnostics. In order to improve image clarity, reduce universal scanning time, and accommodate personalized medicine, its imaging systems leverage AI algorithms into imaging hardware. Siemens Healthineers is committed to innovation in molecular imaging and clinical diagnostics and aims to continue improving patient outcomes.

 

4. FUJIFILM VisualSonics Inc.

Headquarters: Toronto, Canada

FUJIFILM VisualSonics Inc. is a subsidiary of FUJIFILM Holdings that offers ultra-high-frequency ultrasound and photoacoustic imaging solutions for preclinical and clinical research. FUJIFILM VisualSonics is well-known for its Vevo imaging systems in the In-Vivo Imaging Market, which allow real-time visualization of small-animal physiology with remarkable resolution. These products are utilized extensively in research focusing on oncology, cardiovascular medicine, and molecular biology. FUJIFILM VisualSonics focuses on developing non-invasive, high-resolution imaging systems that accurately characterize biological processes.

 

5. MILabs B.V. (Rigaku Company)

Headquarters: Utrecht, Netherlands

MILabs B.V. is a leading innovator in a variety of molecular imaging technologies. MILabs specializes in multimodal imaging platforms that combine the PET, SPECT, CT, and optical modalities for small-animal research applications. With its unique adaptive, high-resolution systems, MILabs has positioned itself as a leader in the In-Vivo Imaging Market, enhancing research accuracy and productivity. The company's U-SPECT systems are used extensively in oncology, neurology, and pharmacology research. The company's unique blend of modularity, innovation, and flexibility.

 

Are you ready to discover more about the In-Vivo Imaging market?

The report provides an in-depth analysis of the leading companies operating in the global In-Vivo Imaging market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

1. PerkinElmer Inc.

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

1. Bruker Corporation
2. Siemens Healthineers AG
3. FUJIFILM VisualSonics Inc.
4. MILabs B.V. (Rigaku Company)
5. Thermo Fisher Scientific Inc.
6. Mediso Medical Imaging Systems Ltd.
7. LI-COR Biosciences
8. MR Solutions Ltd.
9. Others

 

Conclusion

The Worldwide In-Vivo Imaging Market Size is anticipated to experience robust expansion due to rapid technological advancements in imaging modalities, an increasing number of applications in drug discovery, and the rising demand for non-invasive diagnostic tools. Key players, including PerkinElmer, Bruker, Siemens Healthineers, FUJIFILM VisualSonics, and MILabs, are pushing innovation in the market with high-resolution, multimodal imaging systems to enhance research accuracy and improve clinical outcomes. The ongoing growth of this market might also be supported by the technological integration of AI, molecular imaging, and hybrid modalities, to allow researchers and clinicians to be more effective at visualizing disease and monitoring treatment. In-vivo imaging will continue to experience strong global adoption, empowering medical innovation in research and clinical settings, improving patient care, and enabling the development of precision medicine.

 

Browse Related Reports:

Global Canopy Market Size To Exceed USD 2.55 Billion by 2035 | CAGR of 2.86% : Market Study Report

Global Integrated Cloud Management Platform Market Size To Exceed USD 29.32 Billion by 2035 | CAGR of 14.52% : Market Study Report

Global Ground-based Air Defense Systems Market Size To Exceed to USD 40.81 Billion by 2035 | CAGR of 4.1%: Market Study Report

Global Autism Spectrum Disorder Market Size To Exceed USD 4.73 Billion by 2035 | CAGR of 6.44% : Market Study Report

Global Ureteral Access Sheath Market Size To Exceed USD 2.33 Billion by 2035 | CAGR of 4.74% : Market Study Report

 

About the Spherical Insights & Consulting

 

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter